Trial intelligence / Profile preview

Repeated GnRH agonist versus low-dose hCG for PCOS-related infertility

IRCT20110731007165N8Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Dec 2019
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3 trial of gonadotropin-releasing hormone agonist and human chorionic gonadotropin in Polycystic ovary syndrome-related infertility (PCOS) (2 arms), sponsored by Tehran University of Medical Sciences. Started Dec 2019; status: completed.

02

Drugs

gonadotropin-releasing hormone agonisthuman chorionic gonadotropin
03

Conditions

Polycystic ovary syndrome-related infertility (PCOS)

Beyond the preview

Go deeper on IRCT20110731007165N8.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20110731007165N8.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call